Table 1.
Clinicopathological correlation of Slit3 expression in HCC patients
Slit3 overexpression (T/N) | p-value | |||
---|---|---|---|---|
low | high | |||
Age | < 55 | 10 | 7 | 0.523 |
> = 55 | 10 | 13 | ||
Gender | Male | 19 | 15 | 0.182 |
Female | 1 | 5 | ||
HBV infectiona | No | 3 | 3 | 1.000 |
Yes | 15 | 16 | ||
Prior liver-directed treatmentsa | No | 17 | 18 | 0.345 |
Yes | 4 | 1 | ||
Differentiationa | Well | 3 | 5 | 0.682 |
Moderate/Poor | 11 | 10 | ||
Cirrhosisa | No | 14 | 10 | 0.313 |
Yes | 5 | 8 | ||
Tumor Size | <=5 | 3 | 9 | 0.048 |
> 5 | 17 | 11 | ||
Microvascular invasiona | No | 10 | 13 | 0.741 |
Yes | 8 | 7 | ||
Stagea | 1 to 2 | 9 | 11 | 1.000 |
3 to 4 | 9 | 9 | ||
Distant metastasisa | No | 9 | 12 | 1.000 |
Yes | 8 | 9 |
aIn some categories, the total number of patients was less than 40 due to incomplete information